Vor Biopharma Inc. received a notice on April 22, 2025, from Nasdaq stating that its stock price has been below $1.00 for 30 consecutive business days, giving the company until October 20, 2025, to regain compliance. If it fails to do so, it could face delisting but may seek an additional compliance period by transferring to Nasdaq Capital Market.